Enterocolitis: Clinical Trials

16 trials for Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 316Completed 16
Phase 21Completed 1

Follow Enterocolitis: new trials by email Literature Review of Enterocolitis trials Research Report on Enterocolitis

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
RBX2660 - Clostridium Difficile Infection Recurrence
Phase 3CompletedFerring Pharmaceuticals412023-04-212026-04-24
Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis
Pentoxifylline, Probiotic Formula - Necrotizing Enterocolitis
Phase 3CompletedTanta University752022-06-302024-05-20
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
RBX2660 - Clostridium Difficile Infection, Infection
Phase 3CompletedRebiotix Inc.7932019-07-302024-08-07
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
RBX2660, Placebo, Open label RBX2660 (only for confirmed CDI recurrence) - Clostridium Difficile Infection (CDI)
Phase 3CompletedRebiotix Inc.3202017-07-312024-07-10
The Efficacy of Symbiotic on Cytokines
distilled water, symbiotic - Necrotising Enterocolitis
Phase 3CompletedZeynep Kamil Maternity and Pediatric Research and Training Hospital702013-07-012014-08-08
Role of Probiotics for Prevention of NEC in Preterm VLBW Infants
Probiotics, Breast milk - Necrotizing Enterocolitis
Phase 3CompletedSylhet M.A.G.Osmani Medical College602012-07-012016-01-08
Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
Lactobacillus reuteri, Placebo - Necrotizing Enterocolitis, Very Low Birth Weight Infants
Phase 3CompletedZekai Tahir Burak Women's Health Research and Education Hospital4002012-02-012013-05-13
Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants
Probiotic, Placebo - Necrotizing Enterocolitis
Phase 3CompletedUniversity of Stellenbosch1842011-07-012013-07-22
Effect of L-arginine and Glutamine on Preterm
Glutamine, l-arginine - NEC, Sepsis
Phase 2 / Phase 3CompletedAin Shams University752011-05-012014-04-15
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis
Vitamin A - Sepsis, Necrotizing Enterocolitis
Phase 3CompletedJohns Hopkins University4242006-12-012013-09-25
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
Tolevamer potassium-sodium (GT267-004) - Clostridium Enterocolitis, Diarrhea
Phase 3CompletedGenzyme, a Sanofi Company5202005-04-012014-03-19
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
tolevamer potassium-sodium (GT267-004) - Clostridium Enterocolitis, Pseudomembranous Colitis
Phase 3CompletedGenzyme, a Sanofi Company5202005-03-012015-03-05
Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants
probiotics - Nosocomial Infection, Necrotizing Enterocolitis
Phase 3CompletedKing Chulalongkorn Memorial Hospital1602005-01-012011-04-22
Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
Metronidazole and Rifampin - Clostridium Enterocolitis, Antibiotic-Associated Diarrhea
Phase 3CompletedMcMaster University1002004-02-012018-08-15
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
Nitazoxanide - Clostridium Enterocolitis, Pseudomembranous Colitis
Phase 3CompletedDaniel M. Musher MD222004-01-012017-12-15
Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
indomethacin, Indomethacin, Placebo - Infant, Very Low Birth Weight, Infant, Premature
Phase 3CompletedNICHD Neonatal Research Network12021993-11-012015-06-08

Narrower conditions

Enterocolitis, Necrotizing (9)  ·  Enterocolitis, Pseudomembranous (7)  ·  Diarrhea (4)  ·  Clostridium Infections (2)  ·  Premature Birth (2)  ·  Sepsis (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Communicable Diseases (1)  ·  Cross Infection (1)  ·  Ductus Arteriosus, Patent (1)  ·  Infections (1)  ·  Meningitis (1)  ·  Pneumonia (1)

Broader conditions

Digestive System Diseases (16)  ·  Gastroenteritis (16)  ·  Gastrointestinal Diseases (16)  ·  Intestinal Diseases (16)  ·  Infections (10)  ·  Bacterial Infections (7)  ·  Bacterial Infections and Mycoses (7)  ·  Gram-Positive Bacterial Infections (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Clostridium Infections (5)  ·  Pathologic Processes (4)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Digestive (4)  ·  Disease Attributes (2)

Interventions

Probiotics (3)  ·  Arginine (1)  ·  Glutamine (1)  ·  Indomethacin (1)  ·  Metronidazole (1)  ·  Milk, Human (1)  ·  Pentoxifylline (1)  ·  Rifampin (1)  ·  Saline Solution (1)  ·  Single Person (1)  ·  Vitamin A (1)  ·  nitazoxanide (1)

Sponsors

Genzyme, a Sanofi Company (2)  ·  Rebiotix Inc. (2)  ·  Ain Shams University (1)  ·  Daniel M. Musher MD (1)  ·  Ferring Pharmaceuticals (1)  ·  Johns Hopkins University (1)  ·  King Chulalongkorn Memorial Hospital (1)  ·  McMaster University (1)  ·  NICHD Neonatal Research Network (1)  ·  Sylhet M.A.G.Osmani Medical College (1)  ·  Tanta University (1)  ·  University of Stellenbosch (1)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (1)  ·  Zeynep Kamil Maternity and Pediatric Research and Training Hospital (1)

Countries

United States (6)  ·  Canada (4)  ·  Egypt (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Austria (1)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Norway (1)  ·  Portugal (1)

Top investigators

Teena Chopra, M.D., M.P.H. (2)  ·  Avroy A. Fanaroff, MD (1)  ·  Barbara J. Stoll, MD (1)  ·  Barbara Schmidt, MD (1)  ·  Charles R. Bauer, MD (1)  ·  Christian L Coles, PhD (1)  ·  Christine H Lee, MD (1)  ·  Daniel M Musher, M.D. (1)  ·  David K. Stevenson, MD (1)  ·  Evette van Niekerk, M Dietetics (1)  ·  Fahri Ovali (1)  ·  GHada A. Saleh, MRCPCH (1)  ·  Jon E. Tyson, MD MPH (1)

Results publications

PMID 42286373, PMID 24799326, PMID 41245385, PMID 11430325, PMID 12622582, PMID 16647401, PMID 16769377, PMID 17188612, PMID 17307535, PMID 17636753, PMID 18245398, PMID 19117897, PMID 21727276, PMID 24309022, PMID 24919691, PMID 25861285, PMID 36287379, PMID 37564743, PMID 38236515, PMID 39172632, PMID 39180326, PMID 40177588, PMID 40321366, PMID 40552763, PMID 40672762, PMID 40784972, PMID 41115624, PMID 41230019, PMID 41647268, PMID 41653256, PMID 42840322

NIH funding

K01DK075478 (1), M01RR000070 (1), M01RR000997 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD027851 (1), U10HD027880 (1), U10HD027881 (1), U10HD027904 (1), U10HD034216 (1)